series-c-plus
Stage
1
Investors
About
IAI develops mechanistic biomarkers and companion diagnostic tools by harnessing immune memory to improve precision medicine approaches.
Explore IAI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.